Modernizing quality assurance for African pharma & clinical research.
BioKinetyc was founded by life-sciences operations executives and computational biology engineers to eliminate two-week batch release bottlenecks, manual MedDRA adverse-event coding errors, and regulatory dossier delays across African pharmaceutical manufacturing and clinical research.
Replacing Paper Wet-Chemistry Binders with Autonomous Spectral & Clinical Telemetry
Across Nigeria's major pharmaceutical manufacturing zones in Agbara, Enugu, Lagos, and Kano, domestic plants produce millions of essential medicine doses every week. Yet finished batches routinely sit in warehouse quarantine for 14 days waiting for manual HPLC peak integration, dissolution transcription, and paper QA binder signoffs.
Simultaneously, clinical research organizations in Abuja and Ibadan face severe delays coding multi-site adverse events and disbursing investigator grants. BioKinetyc unifies both worlds: combining `AssayVision™` computer vision QC, `VigilanceSentinel™` MedDRA NLP, `TrialEscrow™`, and `DossierLex™` into a single 21 CFR Part 11 operating system.
The founders behind BioKinetyc.
Bridging West African pharmaceutical manufacturing and clinical research with GxP machine learning.
Stephen Nzubechukwu A.
Stephen Nzubechukwu A. leads BioKinetyc’s institutional strategy, pharmaceutical CMO partnerships, and multi-site CRO operations across Nigeria. With deep expertise structuring enterprise B2B telemetry, regulatory compliance automation, and dual-currency escrow governance, he works directly with Directors of Quality Assurance, Qualified Persons, and Principal Investigators across Enugu, Agbara/Lagos, Abuja, and Kano.
- Spearheading autonomous QC and pharmacovigilance deployments across 21 pharma plants, labs, and CROs
- Directing TrialEscrow™ multi-currency clinical investigator payouts and raw API letter-of-credit vaults
- Accelerating WHO-GMP Annex 11 and NAFDAC eCTD regulatory readiness for domestic drug manufacturers
Adeleke Timothy
Adeleke Timothy is a computational biology researcher, computer vision QC architect, and distributed systems engineer with over a decade of experience designing spectral anomaly detection models, clinical NLP transformers, and FDA 21 CFR Part 11 cryptographic audit ledgers. He architected BioKinetyc’s `SpectraViT-QC-v4` and `MedDRA-NLP-v3` engines specifically for African pharmaceutical cleanrooms and clinical trial networks.
- Architected sub-340ms HPLC chromatogram and high-speed tablet coating vision pipelines on NVIDIA TensorRT
- Engineered bidirectional Waters Empower-3, Agilent OpenLab CDS, and SAP QM GxP connectors
- Designed Azure Confidential Computing enclaves for zero-data-retention clinical trial pharmacovigilance
Scientific & GxP Advisory Board
Guiding BioKinetyc on WHO-GMP Annex 11 validation, NAFDAC eCTD standards, and clinical trial ethics.
Prof. Chinedu Nwokoro, FPSN, PhD
25+ years advising West African pharmaceutical manufacturers on WHO Prequalification, USP/BP analytical validation, and NAFDAC eCTD harmonisation.
Dr. Halima Danjuma, MBBS, MPH
Principal investigator and pharmacovigilance specialist overseeing multi-center Phase II–IV infectious disease and oncology cohorts across Nigeria.
Oluwaseun Adeyemi, FCA, CISA
Chartered accountant and certified information systems auditor specializing in GxP computerized system validation (CSV) and cross-border API letter-of-credit escrow.
Registered Operational Headquarters
BioKinetyc maintains validation engineering teams across Nigeria to support pharmaceutical plants, QC laboratories, and CRO sites with on-site cleanroom camera calibration, LIMS integration, and IQ/OQ/PQ qualification.